Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura

Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura

FromJAMA Neurology Author Interviews


Assessment of Erenumab Safety and Efficacy in Migraine With and Without Aura

FromJAMA Neurology Author Interviews

ratings:
Length:
20 minutes
Released:
Dec 20, 2021
Format:
Podcast episode

Description

Interview with Messoud Ashina, MD, DrMSc, author of Assessment of Erenumab Safety and Efficacy in Patients With Migraine With and Without Aura: A Secondary Analysis of Randomized Clinical Trials Hosted by Cynthia E. Armand, MD.
Released:
Dec 20, 2021
Format:
Podcast episode

Titles in the series (100)

Interviews with authors of articles from JAMA Neurology. JAMA Neurology is an international peer-reviewed journal for physicians caring for people with neurologic disorders and those interested in the structure and function of the normal and diseased nervous system.